Patient Information: • Name: [Patient Name] • Age: [Patient Age] • Gender: [Patient Gender] • MRN: [Medical Record Number] • Date of MRI: [Date] • Indication: Evaluation of liver cirrhosis Clinical History: The patient presents with a history of chronic liver disease, elevated liver enzymes, and symptoms suggestive of cirrhosis, including ascites and jaundice. The purpose of the MRI is to assess liver morphology and any associated complications. MRI Technique: MRI of the abdomen was performed using a 1.5 Tesla MRI scanner. The following sequences were obtained: T1-weighted images (in-phase and out-of-phase), T2-weighted images, diffusion-weighted imaging (DWI), and contrast-enhanced imaging following the administration of [contrast agent]. Findings: 1. Liver: • The liver demonstrates a nodular contour with irregular surface, consistent with cirrhosis. • The size of the liver is slightly reduced, measuring approximately [size in cm]. • There is evidence of heterogeneous enhancement on contrast imaging, with areas of low attenuation suggestive of fibrosis and regenerative nodules. • The hepatic parenchyma shows evidence of altered signal intensity on T2-weighted images, indicative of chronic liver disease. 2. Ascites: • There is a moderate amount of ascitic fluid in the abdominal cavity, particularly in the peritoneal recesses, consistent with portal hypertension. 3. Spleen: • The spleen is enlarged, measuring approximately [size in cm], indicative of splenomegaly associated with portal hypertension. 4. Portal Vein: • The portal vein appears patent with no evidence of thrombosis. • There are signs of increased portal vein pressure with the presence of collateral circulation. 5. Biliary System: • The intrahepatic and extrahepatic bile ducts are unremarkable with no signs of dilation or obstruction. 6. Other Findings: • No focal liver lesions suggestive of hepatocellular carcinoma are identified. • The kidneys and other abdominal organs appear within normal limits. Impression: • Findings are consistent with cirrhosis of the liver characterized by nodular morphology, splenomegaly, and moderate ascites. • No evidence of hepatocellular carcinoma at this time. • Recommend clinical correlation and follow-up imaging as necessary to monitor liver status. Recommendations: • Further evaluation of liver function tests. • Consider hepatology consultation for management of cirrhosis and portal hypertension.
